Astronomy star to lead research school
17 May, 2012One of Australia’s foremost astronomers, Professor Matthew Colless, has, today, been announced as the new Director of the Research School of Astronomy and Astrophysics at The Australian National University (ANU).
Top British soil scientist joins UWA
16 May, 2012A leading UK scientist who helped map the bacterial ecosystems of British soil in a world-first study will join The University of Western Australia (UWA) to lead an expert team in soil rehabilitation research.
UQ and Biosceptre collaborate on cancer antibody research
16 May, 2012UniQuest, The University of Queensland’s (UQ) main commercialisation company, has facilitated a strategic research collaboration and antibody production agreement between Australian Institute for Bioengineering and Nanotechnology (AIBN) researchers and Biosceptre International to develop a bioprocess for producing certain monoclonal antibodies for the treatment of cancer.
GE Healthcare Life Sciences completes acquisition of Xcellerex
15 May, 2012GE Healthcare has announced that it has completed the acquisition of Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry.
Gillard government investing in world-class science and research
09 May, 2012The Gillard government intends to secure Australia’s competitive economic edge by boosting funding for science and research in universities by more than $126 million in 2012-13.
IVD Australia welcomes scientist as Head of TGA
07 May, 2012IVD Australia, the industry body representing manufacturers and sponsors of pathology tests, has congratulated Dr John Skerritt on his appointment as the new National Manager of the Therapeutic Goods Administration (TGA).
Qiagen acquires AmniSure International, adds assay to Point of Need portfolio
04 May, 2012 | Supplied by: QIAGEN Pty LtdQiagen NV has announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure assay for determining whether a pregnant woman is suffering rupture of foetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely.
Students win Australian finals of 2012 Imagine Cup with handheld digital stethoscope to detect pneumonia
03 May, 2012A team of Victorian university students has invented a digital stethoscope that could help millions in the developing world by assisting in the early diagnosis of childhood pneumonia. The four students, known as ‘Team StethoCloud’, triumphed against four other teams to win the Australian finals of the 2012 Microsoft Imagine Cup challenge.
Australian researchers receive boost with IP reforms
02 May, 2012Australian researchers now have the freedom to carry out research without the fear of being sued for patent infringement following the introduction of new laws, according to Parliamentary Secretary for Industry and Innovation Mark Dreyfus.
UniQuest and Axiom Molecular sign radiopharma strategic alliance
01 May, 2012UniQuest, The University of Queensland’s (UQ) main commercialisation company, has announced a $4.3 million strategic alliance with Axiom Molecular in radiopharmaceutical research, development and commercialisation.
Australian Red Cross Blood Service launches multimillion-dollar processing facility
30 April, 2012The Australian Red Cross Blood Service is today opening the largest blood processing facility in the Southern Hemisphere, ensuring we continue to have one of the safest blood supply systems in the world.
Academy of Science awards Australia’s top scientists
26 April, 2012The Australian Academy of Science will present its highest awards to eminent scientists on Thursday 3 May 2012 for contributions to their fields of research.
Three Australian Academy of Science Fellows elected to Royal Society
24 April, 2012Three Fellows of the Australian Academy of Science have been elected to the Royal Society of London, the oldest scientific academy in continuous existence. Professor Brian Schmidt, Professor Hugh O’Neill and Dr Trevor McDougall are among 44 scientists elected to the Royal Society in 2012.
Bullish biotech industry set to increase staffing
23 April, 2012Fifty Australian biotechnology companies plan to spend at least $610 million on research and development in 2012 and 82% expect their business to grow this year according to AusBioTech’s annual Biotechnology Industry Position Survey.
ASTM program provides compliance evidence
18 April, 2012A program sponsored and administered by ASTM International - the Supplier’s Declaration of Conformity - will be a major benefit to suppliers, by verifying to their customers their conformance with ASTM test methods.
